Market Place
Sourcing Support
Danaher completes $5.7 billion acquisition of Abcam
07 Dec 2023 //
REUTERS
Shareholders of Abcam Approve Proposed Acquisition by Danaher
07 Nov 2023 //
PRESS RELEASE
Glass Lewis Joins ISS in Recommending Vote “FOR” Danaher’s Proposed Acquisition of Abcam
23 Oct 2023 //
BUSINESSWIRE
Jonathan Milner releases presentation to Abcam plc shareholders
16 Oct 2023 //
GLOBENEWSWIRE
Abcam lays out details behind $5.7B Danaher acquisition
06 Oct 2023 //
ENDPTS
Jonathan Milner issues Open Letter to shareholders of Abcam plc
28 Sep 2023 //
GLOBENEWSWIRE
Abcam plc Statement on Dr. Jonathan Milner’s Announcement
14 Sep 2023 //
BUSINESSWIRE
Abcam plc Interim Results for the Six-Month Period Ended 30 June 2023
31 Aug 2023 //
BUSINESSWIRE
Life sciences firm Danaher to buy Abcam in $5.7 bln deal
29 Aug 2023 //
REUTERS
England`s Abcam weighs its options, which could include a sale
29 Jun 2023 //
FIERCE PHARMA
Lunaphore and Abcam Announce Agreement for Use on COMET
06 Apr 2023 //
BUSINESSWIRE
ABCAM PLC: Final results for the year ended 31 December 2022
20 Mar 2023 //
PR NEWSWIRE
Abcam opens new APAC hub in Singapore
28 Apr 2022 //
BIOSPECTRUMASIA
Abcam, Twist Bioscience Collaborate to Enhance Antibody Discovery
01 Feb 2022 //
BUSINESSWIRE
Alamar Bios, Abcam partner to drive understanding of human proteome
05 Jan 2022 //
PHARMABIZ
Abcam completes $340M strategic acquisition, expands kit capacity and capability
27 Oct 2021 //
BIOSPACE
Abcam brings a longtime collaborator in house as part of $340M buyout pact
03 Aug 2021 //
ENDPTS
Abcam to Acquire BioVision for $340 million
02 Aug 2021 //
GLOBENEWSWIRE
Drug supplier Abcam brings a longtime collaborator in house as part of $340M
02 Aug 2021 //
ENDPTS
Abcam brings a longtime collaborator in house as part of $340M pact
30 Jul 2021 //
ENDPTS
Abcam opens new US facility in Boston, MA
13 Jul 2021 //
PRNEWSWIRE
Pionyr and Abcam extend partnership
22 Jun 2021 //
PRNEWSWIRE
Cancer Research UK and Abcam Launch Custom Partnership to Accelerate Research
07 Jul 2020 //
PRNEWSWIRE
CR UK pairs with Abcam
07 Jul 2020 //
PHARMATIMES
Abcam purchases gene editing platform & oncology product portfolio
30 Jan 2020 //
PHARMABIZ
Abcam Announces Acquisition of Expedeon`s Proteomics and Immunology Business
06 Jan 2020 //
PRESS RELEASE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.